Evidence map›Paper›PMID 41020192›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2025

Early Versus Late Dialysis in Cirrhosis Patients and Septic Shock (ELDICS Study): A Randomized Controlled Trial (NCT02937961).

Rakhi Maiwall, Samba Siva Rao Pasupuleti, Prashant Agarwal, Sherin Thomas, Harsh Vardhan Tevethia, Rajendra Prasad Mathur, Shiv Kumar Sarin

Abstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rakhi MaiwallDepartment of Hepatology Institute of Liver and Biliary Sciences New Delhi India.ORCID https://orcid.org/0000-0003-0110-5982
Samba Siva Rao PasupuletiDepartment of Statistics, Mizoram University (A Central University) Pachhunga University, College Campus Aizawl India.
Prashant AgarwalDepartment of Critical Care Institute of Liver and Biliary Sciences New Delhi India.
Sherin ThomasDepartment of Biochemistry Institute of Liver and Biliary Sciences New Delhi India.
Harsh Vardhan TevethiaDepartment of Hepatology Institute of Liver and Biliary Sciences New Delhi India.
Rajendra Prasad MathurDepartment of Nephrology Institute of Liver and Biliary Sciences New Delhi India.
Shiv Kumar SarinDepartment of Hepatology Institute of Liver and Biliary Sciences New Delhi India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: Critically ill cirrhotics (CIC) pose a management challenge due to severe metabolic and renal impairment. The ideal timing of initiation of dialysis in acute kidney injury (AKI) in CIC is not known. We aimed to compare the safety and efficacy of early (ED) versus late (LD) initiation of sustained low-efficiency dialysis (SLED) in CIC. Methods: CIC were randomized to ED (SLED initiated within 6-12 h) or the LD (where SLED was performed when the patient met absolute criteria) group. Results: Fifty CIC (aged 45.2 ± 10 years), 90% males, 87% alcohol-related, 72% with pneumonia admitted to liver ICU were randomized to ED or LD group. Baseline lactate (mg/dL) (2.7 ± 1.8 vs. 3.3 ± 2.1) and SOFA scores (12.9 ± 2.1 vs. 13.7 ± 4.0) were comparable. Median time to dialysis (in hours) was 7 (IQR 6-8) in ED and 24 (18-48) in LD group. Mortality at 28 days (56% vs. 76%; Conclusions: Timely initiation of dialysis could avert the development or progression of metabolic complications, decrease the incidence of IDH and early deaths in CIC. A higher frequency of recovery of renal functions and reduced AKI-related mortality could be achieved by timely dialysis in CICs.

Indexed as

ACLFCKDCRRTcystatin CNGALsepsis

Identifiers

PMID41020192
PMCPMC12460919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.